Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dynamin 2 inhibitor for the treatment of centronuclear myopathies

Dynamin 2 inhibitor for the treatment of centronuclear myopathies

US Patent 11499155 · Granted Nov 15, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and method for the treatment of x-linked centronuclear myopathy2023
Compositions and method for the treatment of x-linked centronuclear myopathy2023
Dynamin 2 inhibitor for the treatment of Duchenne's muscular dystrophy2020
Dynamin 2 inhibitor for the treatment of Duchenne's muscular dystrophy2020
Dynamin 2 inhibitor for the treatment of centronuclear myopathies2020
Dynamin 2 inhibitor for the treatment of centronuclear myopathies2020
Dynamin 2 inhibitor for the treatment of centronuclear myopathies2020
Tyrosine-phosphatase-related protein2001